GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Resonance Health Ltd (ASX:RHT) » Definitions » Quick Ratio

Resonance Health (ASX:RHT) Quick Ratio : 1.51 (As of Jun. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Resonance Health Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Resonance Health's quick ratio for the quarter that ended in Jun. 2024 was 1.51.

Resonance Health has a quick ratio of 1.51. It generally indicates good short-term financial strength.

The historical rank and industry rank for Resonance Health's Quick Ratio or its related term are showing as below:

ASX:RHT' s Quick Ratio Range Over the Past 10 Years
Min: 1.51   Med: 5.84   Max: 15.83
Current: 1.51

During the past 13 years, Resonance Health's highest Quick Ratio was 15.83. The lowest was 1.51. And the median was 5.84.

ASX:RHT's Quick Ratio is ranked better than
59.56% of 685 companies
in the Healthcare Providers & Services industry
Industry Median: 1.21 vs ASX:RHT: 1.51

Resonance Health Quick Ratio Historical Data

The historical data trend for Resonance Health's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonance Health Quick Ratio Chart

Resonance Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.65 15.83 10.34 8.64 1.51

Resonance Health Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.34 7.85 8.64 8.25 1.51

Competitive Comparison of Resonance Health's Quick Ratio

For the Health Information Services subindustry, Resonance Health's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Resonance Health's Quick Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Resonance Health's Quick Ratio falls into.



Resonance Health Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Resonance Health's Quick Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Quick Ratio (A: Jun. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(9.285-0)/6.147
=1.51

Resonance Health's Quick Ratio for the quarter that ended in Jun. 2024 is calculated as

Quick Ratio (Q: Jun. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(9.285-0)/6.147
=1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Resonance Health  (ASX:RHT) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Resonance Health Quick Ratio Related Terms

Thank you for viewing the detailed overview of Resonance Health's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Resonance Health Business Description

Traded in Other Exchanges
N/A
Address
141-143 Burswood Road, Level 1, Burswood, Perth, WA, AUS, 6100
Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, Cardiac T2, and HepaFat-Scan. It also has several AI-assisted SaMDs including FerriSmart, HepaFat-AI, and LiverSmart. The company's business segments are; Services which derives key revenue, Research and development, Corporate, Clinical Research Organization (CRO), and TrialsWest. Geographically, it generates maximum revenue from the Asia Pacific and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.

Resonance Health Headlines

No Headlines